AC Immune (ACIU) is Initiated by Jefferies to Buy, Price Target at $25

AC Immune (ACIU) was Initiated by Jefferies to “Buy” and the brokerage firm has set the Price Target at $25. Jefferies advised their investors in a research report released on Oct 18, 2016.

AC Immune

Leave a Reply

AC Immune - Is it time to Sell?

Top Brokerage Firms are advising their investors on AC Immune. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.